ANRO
Alto Neuroscience, Inc.
A clinical-stage biopharmaceutical company working in precision psychiatry, Alto Neuroscience uses brain imaging and biomarkers to match people with mental health treatments likely to work for them, rather than the usual trial-and-error approach. It was founded in 2019 by Dr. Amit Etkin, a psychiatrist and neuroscientist and former Stanford professor, building on his years of research. A naming quirk: "Alto" may nod to the Latin for "high" — and to Palo Alto, where Etkin worked at the VA medical center.
CUSIP: 02157Q109HealthcareUS1 holder
Total Value
$373.5K
Total Shares
16.6K
Net Share Change
+16.6K
Activity
1 buying
Investor
Value
Shares
Weight
Change
